{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:47:38Z","timestamp":1787532458612,"version":"build-2736575974"},"reference-count":214,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Atherosclerosis is the pathophysiological basis for major diseases, such as\ncoronary heart disease, cerebral stroke, and peripheral arterial disease, which have become\nepidemic in modern Western society. Atherosclerosis has a complex nature that involves\nmutually related immune and metabolic mechanisms. Many cells of the vascular\nwall and peripheral bloodstream, including endothelial cells, monocytes and\nmacrophages, platelets, and others, are involved in the development and progression of\natherosclerosis. These cells perform a number of innate immune functions, disorders of\nwhich are associated with atherosclerosis. Furthermore, lipids are not only a morphological\nsubstrate but also important participants in the development of atherosclerosis. They\nare involved in the development and resolution of inflammation and mediate vascular\ncell function.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673303369240312092913","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T06:32:26Z","timestamp":1710916346000},"page":"2971-2991","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Involvement of Lipids and Lipid Mediators in Inflammation and Atherogenesis"],"prefix":"10.2174","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-2692","authenticated-orcid":true,"given":"Stanislav","family":"Kotlyarov","sequence":"first","affiliation":[{"name":"Department of Nurse, Ryazan State Medical University, Ryazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jamaneurol.2017.3960","volume":"75","author":"Hoshino T.","year":"2018","unstructured":"Hoshino T.; Sissani L.; Labreuche J.; Ducrocq G.; Lavall\u00e9e P.C.; Meseguer E.; Guidoux C.; Cabrejo L.; Hobeanu C.; Gongora-Rivera F.; Touboul P.J.; Steg P.G.; Amarenco P.; Prevalence of systemic atherosclerosis burdens and overlapping stroke etiologies and their associations with long-term vascular prognosis in stroke with intracranial atherosclerotic disease. JAMA Neurol  2018,75(2),203-211","journal-title":"JAMA Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"868370","DOI":"10.3389\/fcvm.2022.868370","volume":"9","author":"Lin J.","year":"2022","unstructured":"Lin J.; Chen Y.; Jiang N.; Li Z.; Xu S.; Burden of peripheral artery disease and its attributable risk factors in 204 countries and territories from 1990 to 2019. Front Cardiovasc Med  2022,9,868370","journal-title":"Front Cardiovasc Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.puhe.2023.07.010","volume":"223","author":"Guan C.","year":"2023","unstructured":"Guan C.; Wu S.; Xu W.; Zhang J.; Global, regional, and national burden of ischaemic heart disease and its trends, 1990-2019. Public Health  2023,223,57-66","journal-title":"Public Health"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17816\/PAVLOVJ2012142-45","volume":"20","author":"Kalinin R.E.","year":"2012","unstructured":"Kalinin R.E.; Suchkov I.A.; Nikiforov A.A.; Phennikov A.S.; Dynamics of some biochemical parameters in patients with peripheral occlusive arterial disease at different periods following reconstructive surgery. IP Pavlov Russian Medical Biological Herald  2012,20(1),42-45","journal-title":"IP Pavlov Russian Medical Biological Herald"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3390\/diagnostics12102499","volume":"12","author":"Aursulesei Onofrei V.","year":"2022","unstructured":"Aursulesei Onofrei V.; Ceasovschih A.; Marcu D.T.M.; Adam C.A.; Mitu O.; Mitu F.; Mortality risk assessment in peripheral arterial disease-the burden of cardiovascular risk factors over the years: A single center\u2019s experience. Diagnostics  2022,12(10),2499","journal-title":"Diagnostics"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/CM9.0000000000002839","volume":"136","author":"Chen W.","year":"2023","unstructured":"Chen W.; Li Z.; Zhao Y.; Chen Y.; Huang R.; Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the global burden of disease study 2019. Chin Med J  2023,136(20),2442-2450","journal-title":"Chin Med J"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e9349","DOI":"10.7759\/cureus.9349","volume":"12","author":"Khan M.A.B.","year":"2020","unstructured":"Khan M.A.B.; Hashim M.J.; Mustafa H.; Baniyas M.Y.; Al Suwaidi S.K.B.M.; AlKatheeri R.; Alblooshi F.M.K.; Almatrooshi M.E.A.H.; Alzaabi M.E.H.; Al Darmaki R.S.; Lootah S.N.A.H.; Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus  2020,12(7),e9349","journal-title":"Cureus"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jphp.13144","volume":"71","author":"Demir Y.","year":"2019","unstructured":"Demir Y.; The behaviour of some antihypertension drugs on human serum paraoxonase-1: An important protector enzyme against atherosclerosis. J Pharm Pharmacol  2019,71(10),1576-1583","journal-title":"J Pharm Pharmacol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ddr.21667","volume":"81","author":"Demir Y.","year":"2020","unstructured":"Demir Y.; Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking,  and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases. Drug Dev Res  2020,81(5),628-636","journal-title":"Drug Dev Res"},{"key":"ref=10","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198755777.003.0012","author":"Wentzel J.J.","year":"2017","unstructured":"Wentzel J.J.; Rowland E.M.; Weinberg P.D.; Krams R.; Biomechanical theories of atherosclerosis. The ESC Textbook of Vascular Biology  2017","journal-title":"The ESC Textbook of Vascular Biology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.biochi.2015.12.014","volume":"125","author":"Salvayre R.","year":"2016","unstructured":"Salvayre R.; Negre-Salvayre A.; Camar\u00e9 C.; Oxidative theory of atherosclerosis and antioxidants. Biochimie  2016,125,281-296","journal-title":"Biochimie"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1194\/jlr.R043414","volume":"54","author":"Steinberg D.","year":"2013","unstructured":"Steinberg D.; In celebration of the 100th anniversary of the lipid hypothesis of atherosclerosis. J Lipid Res  2013,54(11),2946-2949","journal-title":"J Lipid Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2147\/JMDH.S254016","volume":"13","author":"Minelli S.","year":"2020","unstructured":"Minelli S.; Minelli P.; Montinari M.R.; Reflections on atherosclerosis: Lesson from the past and future research directions. J Multidiscip Healthc  2020,13,621-633","journal-title":"J Multidiscip Healthc"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.ATV.3.2.178","volume":"3","author":"Anitschkow N.","year":"1983","unstructured":"Anitschkow N.; Chalatow S.; Montinari M.R.; Classics in arteriosclerosis research: On experimental cholesterin steatosis and its significance in the origin of some pathological processes translated by Mary Z. Pelias, 1913. Arteriosclerosis  1983,3(2),178-182","journal-title":"Arteriosclerosis"},{"key":"ref=15","first-page":"417","volume":"33","author":"Konstantinov I.E.","year":"2006","unstructured":"Konstantinov I.E.; Mejevoi N.; Anichkov N.M.; Nikolai N.; Anichkov and his theory of atherosclerosis. Tex Heart Inst J  2006,33(4),417-423","journal-title":"Tex Heart Inst J"},{"key":"ref=16","first-page":"631","volume":"38","author":"Capron L.","year":"1989","unstructured":"Capron L.; Pathogenesis of atherosclerosis: An update on the three main theories. Ann Cardiol Angeiol  1989,38(10),631-634","journal-title":"Ann Cardiol Angeiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.carpath.2013.12.004","volume":"23","author":"Buja L.M.","year":"2014","unstructured":"Buja L.M.; Nikolai N.; Anitschkow and the lipid hypothesis of atherosclerosis. Cardiovasc Pathol  2014,23(3),183-184","journal-title":"Cardiovasc Pathol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","volume":"90","author":"Kannel W.B.","year":"1979","unstructured":"Kannel W.B.; Castelli W.P.; Gordon T.; Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med  1979,90(1),85-91","journal-title":"Ann Intern Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach F.","year":"2020","unstructured":"Mach F.; Baigent C.; Catapano A.L.; Koskinas K.C.; Casula M.; Badimon L.; Chapman M.J.; De Backer G.G.; Delgado V.; Ference B.A.; Graham I.M.; Halliday A.; Landmesser U.; Mihaylova B.; Pedersen T.R.; Riccardi G.; Richter D.J.; Sabatine M.S.; Taskinen M.R.; Tokgozoglu L.; Wiklund O.; Mueller C.; Drexel H.; Aboyans V.; Corsini A.; Doehner W.; Farnier M.; Gigante B.; Kayikcioglu M.; Krstacic G.; Lambrinou E.; Lewis B.S.; Masip J.; Moulin P.; Petersen S.; Petronio A.S.; Piepoli M.F.; Pint\u00f3 X.; R\u00e4ber L.; Ray K.K.; Reiner \u017d.; Riesen W.F.; Roffi M.; Schmid J-P.; Shlyakhto E.; Simpson I.A.; Stroes E.; Sudano I.; Tselepis A.D.; Viigimaa M.; Vindis C.; Vonbank A.; Vrablik M.; Vrsalovic M.; Zamorano J.L.; Collet J-P.; Koskinas K.C.; Casula M.; Badimon L.; John Chapman M.; De Backer G.G.; Delgado V.; Ference B.A.; Graham I.M.; Halliday A.; Landmesser U.; Mihaylova B.; Pedersen T.R.; Riccardi G.; Richter D.J.; Sabatine M.S.; Taskinen M-R.; Tokgozoglu L.; Wiklund O.; Windecker S.; Aboyans V.; Baigent C.; Collet J-P.; Dean V.; Delgado V.; Fitzsimons D.; Gale C.P.; Grobbee D.; Halvorsen S.; Hindricks G.; Iung B.; J\u00fcni P.; Katus H.A.; Landmesser U.; Leclercq C.; Lettino M.; Lewis B.S.; Merkely B.; Mueller C.; Petersen S.; Petronio A.S.; Richter D.J.; Roffi M.; Shlyakhto E.; Simpson I.A.; Sousa-Uva M.; Touyz R.M.; Nibouche D.; Zelveian P.H.; Siostrzonek P.; Najafov R.; van de Borne P.; Pojskic B.; Postadzhiyan A.; Kypris L.; \u0160pinar J.; Larsen M.L.; Eldin H.S.; Viigimaa M.; Strandberg T.E.; Ferri\u00e8res J.; Agladze R.; Laufs U.; Rallidis L.; Bajnok L.; Gudj\u00f3nsson T.; Maher V.; Henkin Y.; Gulizia M.M.; Mussagaliyeva A.; Bajraktari G.; Kerimkulova A.; Latkovskis G.; Hamoui O.; Slapikas R.; Visser L.; Dingli P.; Ivanov V.; Boskovic A.; Nazzi M.; Visseren F.; Mitevska I.; Retterst\u00f8l K.; Jankowski P.; Fontes-Carvalho R.; Gaita D.; Ezhov M.; Foscoli M.; Giga V.; Pella D.; Fras Z.; de Isla L.P.; Hagstr\u00f6m E.; Lehmann R.; Abid L.; Ozdogan O.; Mitchenko O.; Patel R.S.; 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J  2020,41(1),111-188","journal-title":"Eur Heart J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/jcm9072140","volume":"9","author":"Meier R.","year":"2020","unstructured":"Meier R.; Rachamin Y.; Rosemann T.; Markun S.; The impact of the 2019 European guideline for cardiovascular risk management: A cross-sectional study in general practice. J Clin Med  2020,9(7),2140","journal-title":"J Clin Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"106873","DOI":"10.1016\/j.phrs.2023.106873","volume":"195","author":"Galimberti F.","year":"2023","unstructured":"Galimberti F.; Casula M.; Olmastroni E.; Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment. Pharmacol Res  2023,195,106873","journal-title":"Pharmacol Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","volume":"4","author":"Sniderman A.D.","year":"2019","unstructured":"Sniderman A.D.; Thanassoulis G.; Glavinovic T.; Navar A.M.; Pencina M.; Catapano A.; Ference B.A.; Apolipoprotein B particles and cardiovascular disease. JAMA Cardiol  2019,4(12),1287-1295","journal-title":"JAMA Cardiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/biomedicines11051424","volume":"11","author":"Bezsonov E.","year":"2023","unstructured":"Bezsonov E.; Khotina V.; Glanz V.; Sobenin I.; Orekhov A.; Lipids and lipoproteins in atherosclerosis. Biomedicines  2023,11(5),1424","journal-title":"Biomedicines"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1515\/bmc-2022-0001","volume":"13","author":"Kotlyarov S.","year":"2022","unstructured":"Kotlyarov S.; Analysis of differentially expressed genes and signaling pathways involved in atherosclerosis and chronic obstructive pulmonary disease. Biomol Concepts  2022,13(1),34-54","journal-title":"Biomol Concepts"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.mpmed.2014.06.011","volume":"42","author":"Douglas G.","year":"2014","unstructured":"Douglas G.; Channon K.M.; The pathogenesis of atherosclerosis. Medicine  2014,42(9),480-484","journal-title":"Medicine"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1161\/ATVBAHA.119.313830","volume":"40","author":"Jiang P.","year":"2020","unstructured":"Jiang P.; Chen Z.; Hippe D.S.; Watase H.; Sun B.; Lin R.; Yang Z.; Xue Y.; Zhao X.; Yuan C.; Association between carotid bifurcation geometry and atherosclerotic plaque vulnerability. Arterioscler Thromb Vasc Biol  2020,40(5),1383-1391","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=27","first-page":"1018","volume":"112","author":"Glagov S.","year":"1988","unstructured":"Glagov S.; Zarins C.; Giddens D.P.; Ku D.N.; Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med  1988,112(10),1018-1031","journal-title":"Arch Pathol Lab Med"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archsurg.134.10.1142","volume":"134","author":"Frangos SG","year":"1960","unstructured":"Frangos SG; Gahtan V; Sumpio B; Localization of atherosclerosis: role of hemodynamics. Arch Surg Chic  1960,134(10),1142-1149","journal-title":"Arch Surg Chic"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1152\/physrev.1995.75.3.519","volume":"75","author":"Davies P.F.","year":"1995","unstructured":"Davies P.F.; Flow-mediated endothelial mechanotransduction. Physiol Rev  1995,75(3),519-560","journal-title":"Physiol Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00047.2009","volume":"91","author":"Chiu J.J.","year":"2011","unstructured":"Chiu J.J.; Chien S.; Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev  2011,91(1),327-387","journal-title":"Physiol Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI97950","volume":"128","author":"Kasikara C.","year":"2018","unstructured":"Kasikara C.; Doran A.C.; Cai B.; Tabas I.; The role of non-resolving inflammation in atherosclerosis. J Clin Invest  2018,128(7),2713-2723","journal-title":"J Clin Invest"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1285754","DOI":"10.3389\/fphar.2023.1285754","volume":"14","author":"Aramouni K.","year":"2023","unstructured":"Aramouni K.; Assaf R.K.; Azar M.; Jabbour K.; Shaito A.; Sahebkar A.; Eid A.A.; Rizzo M.; Eid A.H.; Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries. Front Pharmacol  2023,14,1285754","journal-title":"Front Pharmacol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e14169","DOI":"10.1111\/eci.14169","author":"Sharma H.","year":"2024","unstructured":"Sharma H.; Mossman K.; Austin R.C.; Fatal attractions that trigger inflammation and drive atherosclerotic disease. Eur J Clin Invest  2024,e14169","journal-title":"Eur J Clin Invest"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673279032231214110313","author":"Wang Y.X.","year":"2024","unstructured":"Wang Y.X.; Zheng H.Y.; Zhou K.; Xie H.L.; Ren Z.; Liu H.T.; Liu H.; Zhou Z.X.; Jiang Z.S.; Multifaceted nature of HuR in atherosclerosis development. Curr Med Chem  2024","journal-title":"Curr Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"Soehnlein O.","year":"2021","unstructured":"Soehnlein O.; Libby P.; Targeting inflammation in atherosclerosis: From experimental insights to the clinic. Nat Rev Drug Discov  2021,20(8),589-610","journal-title":"Nat Rev Drug Discov"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"Ross R.","year":"1999","unstructured":"Ross R.; Atherosclerosis: An inflammatory disease. N Engl J Med  1999,340(2),115-126","journal-title":"N Engl J Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","volume":"8","author":"Malekmohammad K.","year":"2021","unstructured":"Malekmohammad K.; Bezsonov E.E.; Rafieian-Kopaei M.; Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med  2021,8,707529","journal-title":"Front Cardiovasc Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1161\/CIRCRESAHA.116.309794","volume":"119","author":"Thorp E.B.","year":"2016","unstructured":"Thorp E.B.; Proresolving lipid mediators restore balance to the vulnerable plaque. Circ Res  2016,119(9),972-974","journal-title":"Circ Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1161\/ATVBAHA.119.312582","volume":"40","author":"Fairman G.","year":"2020","unstructured":"Fairman G.; Robichaud S.; Ouimet M.; Metabolic regulators of vascular inflammation. Arterioscler Thromb Vasc Biol  2020,40(2),e22-e30","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ajpath.2017.01.018","volume":"187","author":"Fredman G.","year":"2017","unstructured":"Fredman G.; Tabas I.; Boosting inflammation resolution in atherosclerosis. Am J Pathol  2017,187(6),1211-1221","journal-title":"Am J Pathol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9582430","volume":"2016","author":"Bobryshev Y.V.","year":"2016","unstructured":"Bobryshev Y.V.; Ivanova E.A.; Chistiakov D.A.; Nikiforov N.G.; Orekhov A.N.; Macrophages and their role in atherosclerosis: Pathophysiology and transcriptome analysis. BioMed Res Int  2016,2016,1-13","journal-title":"BioMed Res Int"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"718432","DOI":"10.3389\/fimmu.2021.718432","volume":"12","author":"Tomas L.","year":"2021","unstructured":"Tomas L.; Prica F.; Schulz C.; Trafficking of mononuclear phagocytes in healthy arteries and atherosclerosis. Front Immunol  2021,12,718432","journal-title":"Front Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/nm.3258","volume":"19","author":"Robbins C.S.","year":"2013","unstructured":"Robbins C.S.; Hilgendorf I.; Weber G.F.; Theurl I.; Iwamoto Y.; Figueiredo J.L.; Gorbatov R.; Sukhova G.K.; Gerhardt L.M.S.; Smyth D.; Zavitz C.C.J.; Shikatani E.A.; Parsons M.; van Rooijen N.; Lin H.Y.; Husain M.; Libby P.; Nahrendorf M.; Weissleder R.; Swirski F.K.; Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med  2013,19(9),1166-1172","journal-title":"Nat Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.micron.2005.10.007","volume":"37","author":"Bobryshev YV.","year":"2006","unstructured":"Bobryshev YV.; Monocyte recruitment and foam cell formation in atherosclerosis. Micron Oxf Engl  2006,37(3),208-222","journal-title":"Micron Oxf Engl"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"Moore K.J.","year":"2011","unstructured":"Moore K.J.; Tabas I.; The cellular biology of macrophages in atherosclerosis. Cell  2011,145(3),341-355","journal-title":"Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/cells12040522","volume":"12","author":"Blagov A.V.","year":"2023","unstructured":"Blagov A.V.; Markin A.M.; Bogatyreva A.I.; Tolstik T.V.; Sukhorukov V.N.; Orekhov A.N.; The role of macrophages in the pathogenesis of atherosclerosis. Cells  2023,12(4),522","journal-title":"Cells"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fimmu.2016.00275","volume":"7","author":"de Gaetano M.","year":"2016","unstructured":"de Gaetano M.; Crean D.; Barry M.; Belton O.; M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis. Front Immunol  2016,7,275","journal-title":"Front Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","volume":"225","author":"St\u00f6ger J.L.","year":"2012","unstructured":"St\u00f6ger J.L.; Gijbels M.J.J.; van der Velden S.; Manca M.; van der Loos C.M.; Biessen E.A.L.; Daemen M.J.A.P.; Lutgens E.; de Winther M.P.J.; Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis  2012,225(2),461-468","journal-title":"Atherosclerosis"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"679797","DOI":"10.3389\/fmolb.2021.679797","volume":"8","author":"Lin P.","year":"2021","unstructured":"Lin P.; Ji H.H.; Li Y.J.; Guo S.D.; Macrophage plasticity and atherosclerosis therapy. Front Mol Biosci  2021,8,679797","journal-title":"Front Mol Biosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"e0193005","DOI":"10.1371\/journal.pone.0193005","volume":"13","author":"Lee S.G.","year":"2018","unstructured":"Lee S.G.; Oh J.; Bong S.K.; Kim J.S.; Park S.; Kim S.; Park S.; Lee S.H.; Jang Y.; Macrophage polarization and acceleration of atherosclerotic plaques in a swine model. PLoS One  2018,13(3),e0193005","journal-title":"PLoS One"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","volume":"94","author":"Davies M.J.","year":"1996","unstructured":"Davies M.J.; Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation  1996,94(8),2013-2020","journal-title":"Circulation"},{"key":"ref=52","first-page":"420","volume":"5","author":"Galv\u00e1n-Pe\u00f1a S.","year":"2014","unstructured":"Galv\u00e1n-Pe\u00f1a S.; O\u2019Neill L.A.J.; Metabolic reprograming in macrophage polarization. Front Immunol  2014,5,420","journal-title":"Front Immunol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"934040","DOI":"10.3389\/fimmu.2022.934040","volume":"13","author":"Sun X.","year":"2022","unstructured":"Sun X.; Li Y.; Deng Q.; Hu Y.; Dong J.; Wang W.; Wang Y.; Li C.; Macrophage polarization, metabolic reprogramming, and inflammatory effects in ischemic heart disease. Front Immunol  2022,13,934040","journal-title":"Front Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"Kelly B.","year":"2015","unstructured":"Kelly B.; O\u2019Neill L.A.J.; Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res  2015,25(7),771-784","journal-title":"Cell Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3389\/fimmu.2019.01462","volume":"10","author":"Viola A.","year":"2019","unstructured":"Viola A.; Munari F.; S\u00e1nchez-Rodr\u00edguez R.; Scolaro T.; Castegna A.; The metabolic signature of macrophage responses. Front Immunol  2019,10,1462","journal-title":"Front Immunol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"Van den Bossche J.","year":"2017","unstructured":"Van den Bossche J.; O\u2019Neill L.A.; Menon D.; Macrophage immunometabolism: Where are we (Going)? Trends Immunol  2017,38(6),395-406","journal-title":"Trends Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00281-017-0656-7","volume":"40","author":"Groh L.","year":"2018","unstructured":"Groh L.; Keating S.T.; Joosten L.A.B.; Netea M.G.; Riksen N.P.; Monocyte and macrophage immunometabolism in atherosclerosis. Semin Immunopathol  2018,40(2),203-214","journal-title":"Semin Immunopathol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1189\/jlb.1111537","volume":"92","author":"Feingold K.R.","year":"2012","unstructured":"Feingold K.R.; Shigenaga J.K.; Kazemi M.R.; McDonald C.M.; Patzek S.M.; Cross A.S.; Moser A.; Grunfeld C.; Mechanisms of triglyceride accumulation in activated macrophages. J Leukoc Biol  2012,92(4),829-839","journal-title":"J Leukoc Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fimmu.2018.00270","volume":"9","author":"Diskin C.","year":"2018","unstructured":"Diskin C.; P\u00e5lsson-McDermott E.M.; Metabolic modulation in macrophage effector function. Front Immunol  2018,9,270","journal-title":"Front Immunol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"Jha A.K.","year":"2015","unstructured":"Jha A.K.; Huang S.C.C.; Sergushichev A.; Lampropoulou V.; Ivanova Y.; Loginicheva E.; Chmielewski K.; Stewart K.M.; Ashall J.; Everts B.; Pearce E.J.; Driggers E.M.; Artyomov M.N.; Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity  2015,42(3),419-430","journal-title":"Immunity"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"Tannahill G.M.","year":"2013","unstructured":"Tannahill G.M.; Curtis A.M.; Adamik J.; Palsson-McDermott E.M.; McGettrick A.F.; Goel G.; Frezza C.; Bernard N.J.; Kelly B.; Foley N.H.; Zheng L.; Gardet A.; Tong Z.; Jany S.S.; Corr S.C.; Haneklaus M.; Caffrey B.E.; Pierce K.; Walmsley S.; Beasley F.C.; Cummins E.; Nizet V.; Whyte M.; Taylor C.T.; Lin H.; Masters S.L.; Gottlieb E.; Kelly V.P.; Clish C.; Auron P.E.; Xavier R.J.; O\u2019Neill L.A.J.; Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature  2013,496(7444),238-242","journal-title":"Nature"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/01.ATV.0000229665.78997.0b","volume":"26","author":"Bostr\u00f6m P.","year":"2006","unstructured":"Bostr\u00f6m P.; Magnusson B.; Svensson P.A.; Wiklund O.; Bor\u00e9n J.; Carlsson L.M.S.; St\u00e5hlman M.; Olofsson S.O.; Hult\u00e9n L.M.; Hypoxia converts human macrophages into triglyceride-loaded foam cells. Arterioscler Thromb Vasc Biol  2006,26(8),1871-1876","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","volume":"118","author":"Yvan-Charvet L.","year":"2008","unstructured":"Yvan-Charvet L.; Welch C.; Pagler T.A.; Ranalletta M.; Lamkanfi M.; Han S.; Ishibashi M.; Li R.; Wang N.; Tall A.R.; Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation  2008,118(18),1837-1847","journal-title":"Circulation"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1194\/jlr.M006486","volume":"51","author":"Zhu X.","year":"2010","unstructured":"Zhu X.; Owen J.S.; Wilson M.D.; Li H.; Griffiths G.L.; Thomas M.J.; Hiltbold E.M.; Fessler M.B.; Parks J.S.; Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res  2010,51(11),3196-3206","journal-title":"J Lipid Res"},{"key":"ref=65","author":"Burnett J.R.","year":"1993","unstructured":"Burnett J.R.; Hooper A.J.; McCormick S.P.; Hegele R.A.; Adam M.P.; Feldman J.; Mirzaa G.M.; Pagon R.A.; Wallace S.E.; Bean L.J.; Tangier disease. GeneReviews  1993","journal-title":"GeneReviews"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3892\/etm.2012.576","volume":"4","author":"Liu H.F.","year":"2012","unstructured":"Liu H.F.; Cui K.F.; Wang J.P.; Zhang M.; Guo Y.P.; Li X.Y.; Jiang C.; Significance of ABCA1 in human carotid atherosclerotic plaques. Exp Ther Med  2012,4(2),297-302","journal-title":"Exp Ther Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1161\/01.STR.0000147036.07307.93","volume":"35","author":"Albrecht C.","year":"2004","unstructured":"Albrecht C.; Soumian S.; Amey J.S.; Sardini A.; Higgins C.F.; Davies A.H.; Gibbs R.G.J.; ABCA1 expression in carotid atherosclerotic plaques. Stroke  2004,35(12),2801-2806","journal-title":"Stroke"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1073\/pnas.092327399","volume":"99","author":"Van Eck M.","year":"2002","unstructured":"Van Eck M.; Bos I.S.T.; Kaminski W.E.; Ors\u00f3 E.; Rothe G.; Twisk J.; B\u00f6ttcher A.; Van Amersfoort E.S.; Christiansen-Weber T.A.; Fung-Leung W.P.; Van Berkel T.J.C.; Schmitz G.; Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci  2002,99(9),6298-6303","journal-title":"Proc Natl Acad Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1073\/pnas.012587699","volume":"99","author":"Joyce C.W.","year":"2002","unstructured":"Joyce C.W.; Amar M.J.A.; Lambert G.; Vaisman B.L.; Paigen B.; Najib-Fruchart J.; Hoyt R.F.; Neufeld E.D.; Remaley A.T.; Fredrickson D.S.; Brewer H.B.; Santamarina-Fojo S.; The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice. Proc Natl Acad Sci  2002,99(1),407-412","journal-title":"Proc Natl Acad Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"103324","DOI":"10.1016\/j.ebiom.2021.103324","volume":"66","author":"Thomas C.","year":"2021","unstructured":"Thomas C.; Gautier T.; Masson D.; Non-lipogenic ABCA1 inducers: The holy grail in cardio-metabolic diseases? EBioMedicine  2021,66,103324","journal-title":"EBioMedicine"},{"key":"ref=71","first-page":"4273","volume":"180","author":"Wojcik AJ","year":"1950","unstructured":"Wojcik AJ; Skaflen MD; Srinivasan S; Hedrick CC.; A critical role for ABCG1 in macrophage inflammation and lung homeostasis. J Immunol Baltim Md  1950,180(6),4273-4282","journal-title":"J Immunol Baltim Md"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.1890023","volume":"202","author":"Sag D","year":"2019","unstructured":"Sag D; Purcu DU; Altunay M.; The cholesterol transporter ABCG1 modulates macrophage polarization in human monocyte-derived macrophages. J Immunol  2019,202(1),1-187","journal-title":"J Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1038\/ncomms7354","volume":"6","author":"Sag D.","year":"2015","unstructured":"Sag D.; Cekic C.; Wu R.; Linden J.; Hedrick C.C.; The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity. Nat Commun  2015,6(1),6354","journal-title":"Nat Commun"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e2107682118","DOI":"10.1073\/pnas.2107682118","volume":"118","author":"Zhang X.","year":"2021","unstructured":"Zhang X.; McDonald J.G.; Aryal B.; Canfr\u00e1n-Duque A.; Goldberg E.L.; Araldi E.; Ding W.; Fan Y.; Thompson B.M.; Singh A.K.; Li Q.; Tellides G.; Ordov\u00e1s-Montanes J.; Garc\u00eda Milian R.; Dixit V.D.; Ikonen E.; Su\u00e1rez Y.; Fern\u00e1ndez-Hernando C.; Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis. Proc Natl Acad Sci  2021,118(47),e2107682118","journal-title":"Proc Natl Acad Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2010.04.006","volume":"11","author":"Smoak K.A.","year":"2010","unstructured":"Smoak K.A.; Aloor J.J.; Madenspacher J.; Merrick B.A.; Collins J.B.; Zhu X.; Cavigiolio G.; Oda M.N.; Parks J.S.; Fessler M.B.; Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab  2010,11(6),493-502","journal-title":"Cell Metab"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCULATIONAHA.108.810721","volume":"119","author":"McGillicuddy F.C.","year":"2009","unstructured":"McGillicuddy F.C.; de la Llera Moya M.; Hinkle C.C.; Joshi M.R.; Chiquoine E.H.; Billheimer J.T.; Rothblat G.H.; Reilly M.P.; Inflammation impairs reverse cholesterol transport in vivo. Circulation  2009,119(8),1135-1145","journal-title":"Circulation"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","volume":"23","author":"Barter P.J.","year":"2003","unstructured":"Barter P.J.; Brewer H.B.; Chapman M.J.; Hennekens C.H.; Rader D.J.; Tall A.R.; Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol  2003,23(2),160-167","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"10E","DOI":"10.1016\/j.amjcard.2009.09.014","volume":"104","author":"Barter P.","year":"2009","unstructured":"Barter P.; Lessons learned from the investigation of lipid level management to understand its impact in atherosclerotic events (ILLUMINATE) trial. Am J Cardiol  2009,104(10),10E-15E","journal-title":"Am J Cardiol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"Sezgin E.","year":"2017","unstructured":"Sezgin E.; Levental I.; Mayor S.; Eggeling C.; The mystery of membrane organization: Composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol  2017,18(6),361-374","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/42408","volume":"387","author":"Simons K.","year":"1997","unstructured":"Simons K.; Ikonen E.; Functional rafts in cell membranes. Nature  1997,387(6633),569-572","journal-title":"Nature"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13062-014-0032-7","volume":"9","author":"Lombard J.","year":"2014","unstructured":"Lombard J.; Once upon a time the cell membranes: 175 years of cell boundary research. Biol Direct  2014,9(1),32","journal-title":"Biol Direct"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12013-017-0792-7","volume":"75","author":"Subczynski W.K.","year":"2017","unstructured":"Subczynski W.K.; Pasenkiewicz-Gierula M.; Widomska J.; Mainali L.; Raguz M.; High cholesterol\/low cholesterol: Effects in biological membranes: A review. Cell Biochem Biophys  2017,75(3-4),369-385","journal-title":"Cell Biochem Biophys"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fphys.2013.00031","volume":"4","author":"Fantini J.","year":"2013","unstructured":"Fantini J.; Barrantes F.J.; How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol  2013,4,31","journal-title":"Front Physiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"Fantini J.","year":"2009","unstructured":"Fantini J.; Barrantes F.J.; Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Bio Biophys Acta Biomembr  2009,1788(11),2345-2361","journal-title":"Bio Biophys Acta Biomembr"},{"key":"ref=85","first-page":"1245","volume":"21","author":"Ayee M.A.","year":"2016","unstructured":"Ayee M.A.; Levitan I.; Paradoxical impact of cholesterol on lipid packing and cell stiffness. FBL  2016,21(6),1245-1259","journal-title":"FBL"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.chemphyslip.2016.04.001","volume":"199","author":"Marquardt D.","year":"2016","unstructured":"Marquardt D.; Ku\u010derka N.; Wassall S.R.; Harroun T.A.; Katsaras J.; Cholesterol\u2019s location in lipid bilayers. Chem Phys Lipids  2016,199,17-25","journal-title":"Chem Phys Lipids"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.bbamem.2015.03.014","volume":"1848","author":"Ruysschaert J.M.","year":"2015","unstructured":"Ruysschaert J.M.; Lonez C.; Role of lipid microdomains in TLR-mediated signalling. Biochim Biophys Acta Biomembr  2015,1848(9),1860-1867","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fimmu.2017.00527","volume":"8","author":"Sancho D.","year":"2017","unstructured":"Sancho D.; Enamorado M.; Garaude J.; Innate immune function of mitochondrial metabolism. Front Immunol  2017,8,527","journal-title":"Front Immunol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5551\/jat.10249","volume":"19","author":"Nicolaou G.","year":"2012","unstructured":"Nicolaou G.; Goodall A.H.; Erridge C.; Diverse bacteria promote macrophage foam cell formation via Toll-like receptor-dependent lipid body biosynthesis. J Atheroscler Thromb  2012,19(2),137-148","journal-title":"J Atheroscler Thromb"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"Michelsen K.S.","year":"2004","unstructured":"Michelsen K.S.; Wong M.H.; Shah P.K.; Zhang W.; Yano J.; Doherty T.M.; Akira S.; Rajavashisth T.B.; Arditi M.; Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci  2004,101(29),10679-10684","journal-title":"Proc Natl Acad Sci"},{"key":"ref=91","first-page":"158702","volume":"1865","author":"Ebert R","year":"2020","unstructured":"Ebert R; Cumbana R; Lehmann C; Kutzner L; Toewe A; Ferreir\u00f3s N; Long-term stimulation of toll-like receptor-2 and -4 upregulates 5-LO and 15-LO-2 expression thereby inducing a lipid mediator shift in human monocyte-derived macrophages. Biochim Biophys Acta BBA - Mol Cell Biol Lipids  2020,1865(9),158702","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1161\/ATVBAHA.120.314330","volume":"40","author":"Shao Y.","year":"2020","unstructured":"Shao Y.; Saredy J.; Yang W.Y.; Sun Y.; Lu Y.; Saaoud F.; Drummer C.; Johnson C.; Xu K.; Jiang X.; Wang H.; Yang X.; Vascular endothelial cells and innate immunity. Arterioscler Thromb Vasc Biol  2020,40(6),e138-e152","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1756-8722-6-61","volume":"6","author":"Mai J.","year":"2013","unstructured":"Mai J.; Virtue A.; Shen J.; Wang H.; Yang X.F.; An evolving new paradigm: Endothelial cells: Conditional innate immune cells. J Hematol Oncol  2013,6(1),61","journal-title":"J Hematol Oncol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cvr\/cvz046","volume":"116","author":"Qu D.","year":"2020","unstructured":"Qu D.; Wang L.; Huo M.; Song W.; Lau C.W.; Xu J.; Xu A.; Yao X.; Chiu J.J.; Tian X.Y.; Huang Y.; Focal TLR4 activation mediates disturbed flow-induced endothelial inflammation. Cardiovasc Res  2020,116(1),226-236","journal-title":"Cardiovasc Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fimmu.2017.00837","volume":"8","author":"Tang C.Y.","year":"2017","unstructured":"Tang C.Y.; Mauro C.; Similarities in the metabolic reprogramming of immune system and endothelium. Front Immunol  2017,8,837","journal-title":"Front Immunol"},{"key":"ref=96","first-page":"141","volume":"16","author":"Sachs F.","year":"1988","unstructured":"Sachs F.; Mechanical transduction in biological systems. Crit Rev Biomed Eng  1988,16(2),141-169","journal-title":"Crit Rev Biomed Eng"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1098\/rstb.2007.2128","volume":"362","author":"White C.R.","year":"2007","unstructured":"White C.R.; Frangos J.A.; The shear stress of it all: The cell membrane and mechanochemical transduction. Philos Trans R Soc Lond B Biol Sci  2007,362(1484),1459-1467","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1242\/jcs.119628","volume":"126","author":"Yamamoto K.","year":"2013","unstructured":"Yamamoto K.; Ando J.; Endothelial cell and model membranes respond to shear stress by rapidly decreasing the order of their lipid phases. J Cell Sci  2013,126(5),1227-1234","journal-title":"J Cell Sci"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"33660","DOI":"10.1073\/pnas.2014029117","volume":"117","author":"Yamamoto K.","year":"2020","unstructured":"Yamamoto K.; Nogimori Y.; Imamura H.; Ando J.; Shear stress activates mitochondrial oxidative phosphorylation by reducing plasma membrane cholesterol in vascular endothelial cells. Proc Natl Acad Sci  2020,117(52),33660-33667","journal-title":"Proc Natl Acad Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"C962","DOI":"10.1152\/ajpcell.2001.280.4.C962","volume":"280","author":"Butler P.J.","year":"2001","unstructured":"Butler P.J.; Norwich G.; Weinbaum S.; Chien S.; Shear stress induces a time- and position-dependent increase in endothelial cell membrane fluidity. Am J Physiol Cell Physiol  2001,280(4),C962-C969","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12195-010-0136-9","volume":"4","author":"Tabouillot T.","year":"2011","unstructured":"Tabouillot T.; Muddana H.S.; Butler P.J.; Endothelial cell membrane sensitivity to shear stress is lipid domain dependent. Cell Mol Bioeng  2011,4(2),169-181","journal-title":"Cell Mol Bioeng"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"H1178","DOI":"10.1152\/ajpheart.00241.2015","volume":"309","author":"Yamamoto K.","year":"2015","unstructured":"Yamamoto K.; Ando J.; Vascular endothelial cell membranes differentiate between stretch and shear stress through transitions in their lipid phases. Am J Physiol Heart Circ Physiol  2015,309(7),H1178-H1185","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1253\/circj.CJ-18-0052","volume":"82","author":"Yamamoto K.","year":"2018","unstructured":"Yamamoto K.; Ando J.; Emerging role of plasma membranes in vascular endothelial mechanosensing. Circ J  2018,82(11),2691-2698","journal-title":"Circ J"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1529\/biophysj.104.040634","volume":"87","author":"Byfield F.J.","year":"2004","unstructured":"Byfield F.J.; Aranda-Espinoza H.; Romanenko V.G.; Rothblat G.H.; Levitan I.; Cholesterol depletion increases membrane stiffness of aortic endothelial cells. Biophys J  2004,87(5),3336-3343","journal-title":"Biophys J"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.biopha.2018.07.122","volume":"106","author":"Su Q.","year":"2018","unstructured":"Su Q.; Sun Y.; Ye Z.; Yang H.; Li L.; Oxidized low density lipoprotein induces endothelial-to-mesenchymal transition by stabilizing Snail in human aortic endothelial cells. Biomed Pharmacother  2018,106,1720-1726","journal-title":"Biomed Pharmacother"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3390\/cells12091293","volume":"12","author":"Higashi Y.","year":"2023","unstructured":"Higashi Y.; Endothelial function in dyslipidemia: roles of ldl-cholesterol, hdl-cholesterol and triglycerides. Cells  2023,12(9),1293","journal-title":"Cells"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/cvr\/cvn111","volume":"79","author":"Hirao A.","year":"2008","unstructured":"Hirao A.; Kondo K.; Takeuchi K.; Inui N.; Umemura K.; Ohashi K.; Watanabe H.; Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries. Cardiovasc Res  2008,79(1),161-168","journal-title":"Cardiovasc Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"121390","DOI":"10.1155\/2012\/121390","volume":"2012","author":"Qian H.","year":"2012","unstructured":"Qian H.; Luo N.; Chi Y.; Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disorders. J Aging Res  2012,2012(1),121390","journal-title":"J Aging Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1172\/JCI200421446","volume":"114","author":"Kobayashi T.","year":"2004","unstructured":"Kobayashi T.; Tahara Y.; Matsumoto M.; Iguchi M.; Sano H.; Murayama T.; Arai H.; Oida H.; Yurugi-Kobayashi T.; Yamashita J.K.; Katagiri H.; Majima M.; Yokode M.; Kita T.; Narumiya S.; Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest  2004,114(6),784-794","journal-title":"J Clin Invest"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/926968","volume":"2012","author":"Dorris S.L.","year":"2012","unstructured":"Dorris S.L.; Peebles R.S.; PGI2 as a regulator of inflammatory diseases. Mediators Inflamm  2012,2012,1-9","journal-title":"Mediators Inflamm"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fcell.2018.00100","volume":"6","author":"Fitzgerald G.","year":"2018","unstructured":"Fitzgerald G.; Soro-Arnaiz I.; De Bock K.; The warburg effect in endothelial cells and its potential as an anti-angiogenic target in cancer. Front Cell Dev Biol  2018,6,100","journal-title":"Front Cell Dev Biol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"16737","DOI":"10.1016\/S0021-9258(17)44821-6","volume":"265","author":"Fu J.Y.","year":"1990","unstructured":"Fu J.Y.; Masferrer J.L.; Seibert K.; Raz A.; Needleman P.; The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem  1990,265(28),16737-16740","journal-title":"J Biol Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","volume":"325","author":"Clarke R.J.","year":"1991","unstructured":"Clarke R.J.; Mayo G.; Price P.; FitzGerald G.A.; Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med  1991,325(16),1137-1141","journal-title":"N Engl J Med"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.CIR.102.8.840","volume":"102","author":"Belton O.","year":"2000","unstructured":"Belton O.; Byrne D.; Kearney D.; Leahy A.; Fitzgerald D.J.; Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation  2000,102(8),840-845","journal-title":"Circulation"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2008.01.001","volume":"118","author":"Nakahata N.","year":"2008","unstructured":"Nakahata N.; Thromboxane A2: Physiology\/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther  2008,118(1),18-35","journal-title":"Pharmacol Ther"},{"key":"ref=116","first-page":"179","volume":"34","author":"Miner J.","year":"2007","unstructured":"Miner J.; Hoffhines A.; The discovery of aspirin\u2019s antithrombotic effects. Tex Heart Inst J  2007,34(2),179-186","journal-title":"Tex Heart Inst J"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/hy1201.096532","volume":"38","author":"Fisslthaler B","year":"1979","unstructured":"Fisslthaler B; Popp R; Michaelis UR; Kiss L; Fleming I; Busse R.; Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase. Hypertens Dallas Tex  1979,38(6),1427-1432","journal-title":"Hypertens Dallas Tex"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"H1113","DOI":"10.1152\/ajpheart.2001.280.3.H1113","volume":"280","author":"Pratt P.F.","year":"2001","unstructured":"Pratt P.F.; Li P.; Hillard C.J.; Kurian J.; Campbell W.B.; Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. Am J Physiol Heart Circ Physiol  2001,280(3),H1113-H1121","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=119","volume":"57","author":"Capozzi M.E.","year":"2016","unstructured":"Capozzi M.E.; Penn J.S.; Epoxydocosapentaenoic acid (EDP) and epoxyeicosatrienoic acid (EET) affect TNF\u03b1 production and leukocyte adhesion in diabetic retinopathy. Invest Ophthalmol Vis Sci  2016,57(12)","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/01.RES.0000019742.48706.F0","volume":"90","author":"Fleming I.","year":"2002","unstructured":"Fleming I.; To move or not to move? Cytochrome P450 products and cell migration. Circ Res  2002,90(9),936-938","journal-title":"Circ Res"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2014.01.045","volume":"727","author":"Jiang J.X","year":"2014","unstructured":"Jiang J.X; Zhang S.J; Liu Y.N; EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells. Eur J Pharmacol  2014,727,43-51","journal-title":"Eur J Pharmacol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"0105","DOI":"10.31083\/j.fbl2703105","volume":"27","author":"Shaito A.","year":"2022","unstructured":"Shaito A.; Aramouni K.; Assaf R.; Parenti A.; Orekhov A.; Yazbi A.E.; Pintus G.; Eid A.H.; Oxidative stress-induced endothelial dysfunction in cardiovascular diseases. Frontiers in Bioscience-Landmark  2022,27(3),0105","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"Hannun Y.A.","year":"2008","unstructured":"Hannun Y.A.; Obeid L.M.; Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol  2008,9(2),139-150","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"4806541","DOI":"10.1155\/2017\/4806541","volume":"2017","author":"Hait N.C.","year":"2017","unstructured":"Hait N.C.; Maiti A.; The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer. Mediators Inflamm  2017,2017(1),4806541","journal-title":"Mediators Inflamm"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","volume":"61","author":"Gomez-Mu\u00f1oz A.","year":"2016","unstructured":"Gomez-Mu\u00f1oz A.; Presa N.; Gomez-Larrauri A.; Rivera I.G.; Trueba M.; Ordo\u00f1ez M.; Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res  2016,61,51-62","journal-title":"Prog Lipid Res"},{"key":"ref=126","first-page":"1060","volume":"1831","author":"Gomez-Mu\u00f1oz A","year":"2013","unstructured":"Gomez-Mu\u00f1oz A; Gangoiti P; Arana L; Ouro A; Rivera IG; Ordo\u00f1ez M; New insights on the role of ceramide 1-phosphate in inflammation. Biochim Biophys Acta BBA - Mol Cell Biol Lipids  2013,1831(6),1060-1066","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3390\/ijms20020411","volume":"20","author":"Cogolludo A.","year":"2019","unstructured":"Cogolludo A.; Villamor E.; Perez-Vizcaino F.; Moreno L.; Ceramide and regulation of vascular tone. Int J Mol Sci  2019,20(2),411","journal-title":"Int J Mol Sci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"e022852","DOI":"10.1161\/JAHA.121.022852","volume":"11","author":"Akhiyat N.","year":"2022","unstructured":"Akhiyat N.; Vasile V.; Ahmad A.; Sara J.D.; Nardi V.; Lerman L.O.; Jaffe A.; Lerman A.; Plasma ceramide levels are elevated in patients with early coronary atherosclerosis and endothelial dysfunction. J Am Heart Assoc  2022,11(7),e022852","journal-title":"J Am Heart Assoc"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","volume":"38","author":"Meeusen J.W.","year":"2018","unstructured":"Meeusen J.W.; Donato L.J.; Bryant S.C.; Baudhuin L.M.; Berger P.B.; Jaffe A.S.; Plasma ceramides. Arterioscler Thromb Vasc Biol  2018,38(8),1933-1939","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"108258","DOI":"10.1016\/j.pharmthera.2022.108258","volume":"237","author":"Manke M.C.","year":"2022","unstructured":"Manke M.C.; Ahrends R.; Borst O.; Platelet lipid metabolism in vascular thrombo-inflammation. Pharmacol Ther  2022,237,108258","journal-title":"Pharmacol Ther"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1172\/JCI26891","volume":"115","author":"Patel S.R.","year":"2005","unstructured":"Patel S.R.; Hartwig J.H.; Italiano J.E.; The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest  2005,115(12),3348-3354","journal-title":"J Clin Invest"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.2515","volume":"17","author":"Jackson S.P.","year":"2011","unstructured":"Jackson S.P.; Arterial thrombosis-insidious, unpredictable and deadly. Nat Med  2011,17(11),1423-1436","journal-title":"Nat Med"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","volume":"122","author":"Koupenova M.","year":"2018","unstructured":"Koupenova M.; Clancy L.; Corkrey H.A.; Freedman J.E.; Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res  2018,122(2),337-351","journal-title":"Circ Res"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1182\/blood-2013-05-468694","volume":"122","author":"Gawaz M.","year":"2013","unstructured":"Gawaz M.; Vogel S.; Platelets in tissue repair: Control of apoptosis and interactions with regenerative cells. Blood  2013,122(15),2550-2554","journal-title":"Blood"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"Gawaz M.","year":"2005","unstructured":"Gawaz M.; Langer H.; May A.E.; Platelets in inflammation and atherogenesis. J Clin Invest  2005,115(12),3378-3384","journal-title":"J Clin Invest"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.tips.2017.08.001","volume":"38","author":"Tourdot B.E.","year":"2017","unstructured":"Tourdot B.E.; Holinstat M.; Targeting 12-lipoxygenase as a potential novel antiplatelet therapy. Trends Pharmacol Sci  2017,38(11),1006-1015","journal-title":"Trends Pharmacol Sci"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF02533876","volume":"14","author":"Dutilh C.E.","year":"1979","unstructured":"Dutilh C.E.; Haddeman E.; Jouvenaz G.H.; Ten Hoor F.; Nugteren D.H.; Study of the two pathways for arachidonate oxygenation in blood platelets. Lipids  1979,14(2),241-246","journal-title":"Lipids"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jchromb.2014.03.015","volume":"964","author":"Porro B.","year":"2014","unstructured":"Porro B.; Songia P.; Squellerio I.; Tremoli E.; Cavalca V.; Analysis, physiological and clinical significance of 12-HETE: A neglected platelet-derived 12-lipoxygenase product. J Chromatogr B Analyt Technol Biomed Life Sci  2014,964,26-40","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","volume":"16","author":"Basatemur G.L.","year":"2019","unstructured":"Basatemur G.L.; J\u00f8rgensen H.F.; Clarke M.C.H.; Bennett M.R.; Mallat Z.; Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol  2019,16(12),727-744","journal-title":"Nat Rev Cardiol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"106924","DOI":"10.1016\/j.vph.2021.106924","volume":"141","author":"Buono M.F.","year":"2021","unstructured":"Buono M.F.; Slenders L.; Wesseling M.; Hartman R.J.G.; Monaco C.; den Ruijter H.M.; Pasterkamp G.; Mokry M.; The changing landscape of the vulnerable plaque: A call for fine-tuning of preclinical models. Vascul Pharmacol  2021,141,106924","journal-title":"Vascul Pharmacol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/ATVBAHA.119.312434","volume":"39","author":"Wang Y.","year":"2019","unstructured":"Wang Y.; Dubland J.A.; Allahverdian S.; Asonye E.; Sahin B.; Jaw J.E.; Sin D.D.; Seidman M.A.; Leeper N.J.; Francis G.A.; Smooth muscle cells contribute the majority of foam cells in ApoE (Apolipoprotein E)-deficient mouse atherosclerosis. Arterioscler Thromb Vasc Biol  2019,39(5),876-887","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.08.012","volume":"358","author":"Sawma T.","year":"2022","unstructured":"Sawma T.; Shaito A.; Najm N.; Sidani M.; Orekhov A.; El-Yazbi A.F.; Iratni R.; Eid A.H.; Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: Implications for vascular function. Atherosclerosis  2022,358,12-28","journal-title":"Atherosclerosis"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"jcp.31200","DOI":"10.1002\/jcp.31200","author":"Elmarasi M.","year":"2024","unstructured":"Elmarasi M.; Elmakaty I.; Elsayed B.; Elsayed A.; Zein J.A.; Boudaka A.; Eid A.H.; Phenotypic switching of vascular smooth muscle cells in atherosclerosis, hypertension, and aortic dissection. J Cell Physiol  2024,jcp.31200","journal-title":"J Cell Physiol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.atherosclerosis.2022.11.021","volume":"374","author":"Fasolo F.","year":"2023","unstructured":"Fasolo F.; Paloschi V.; Maegdefessel L.; Long non-coding RNAs at the crossroad of vascular smooth muscle cell phenotypic modulation in atherosclerosis and neointimal formation. Atherosclerosis  2023,374,34-43","journal-title":"Atherosclerosis"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"H613","DOI":"10.1152\/ajpheart.00220.2020","volume":"319","author":"Shi J.","year":"2020","unstructured":"Shi J.; Yang Y.; Cheng A.; Xu G.; He F.; Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol  2020,319(3),H613-H631","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s42003-022-04255-2","volume":"5","author":"Xue Y.","year":"2022","unstructured":"Xue Y.; Luo M.; Hu X.; Li X.; Shen J.; Zhu W.; Huang L.; Hu Y.; Guo Y.; Liu L.; Wang L.; Luo S.; Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1\u03b2\/STAT3 signaling. Commun Biol  2022,5(1),1316","journal-title":"Commun Biol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms23010340","volume":"23","author":"Burger F.","year":"2021","unstructured":"Burger F.; Baptista D.; Roth A.; da Silva R.F.; Montecucco F.; Mach F.; Brandt K.J.; Miteva K.; NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis. Int J Mol Sci  2021,23(1),340","journal-title":"Int J Mol Sci"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000447880","volume":"39","author":"Li L.","year":"2016","unstructured":"Li L.; Li Y.; Dai Z.; Liu M.; Wang B.; Liu S.; Wang L.; Chen L.; Tan Y.; Wu G.; Lipid metabolism in vascular smooth muscle cells infuenced by HCMV infection. Cell Physiol Biochem  2016,39(5),1804-1812","journal-title":"Cell Physiol Biochem"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.3390\/ijms21228764","volume":"21","author":"Badran A.","year":"2020","unstructured":"Badran A.; Nasser S.A.; Mesmar J.; El-Yazbi A.F.; Bitto A.; Fardoun M.M.; Baydoun E.; Eid A.H.; Reactive oxygen species: Modulators of phenotypic switch of vascular smooth muscle cells. Int J Mol Sci  2020,21(22),8764","journal-title":"Int J Mol Sci"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"17818","DOI":"10.1038\/s41598-020-73751-4","volume":"10","author":"Anagnostopoulou A.","year":"2020","unstructured":"Anagnostopoulou A.; Camargo L.L.; Rodrigues D.; Montezano A.C.; Touyz R.M.; Importance of cholesterol-rich microdomains in the regulation of Nox isoforms and redox signaling in human vascular smooth muscle cells. Sci Rep  2020,10(1),17818","journal-title":"Sci Rep"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"36552","DOI":"10.1038\/srep36552","volume":"6","author":"Wang H.","year":"2016","unstructured":"Wang H.; Robichaux W.G.; Wang Z.; Mei F.C.; Cai M.; Du G.; Chen J.; Cheng X.; Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury. Sci Rep  2016,6(1),36552","journal-title":"Sci Rep"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.3390\/ijms21145160","volume":"21","author":"Wehbe N.","year":"2020","unstructured":"Wehbe N.; Nasser S.A.; Al-Dhaheri Y.; Iratni R.; Bitto A.; El-Yazbi A.F.; Badran A.; Kobeissy F.; Baydoun E.; Eid A.H.; EPAC in vascular smooth muscle cells. Int J Mol Sci  2020,21(14),5160","journal-title":"Int J Mol Sci"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1161\/ATVBAHA.115.306534","volume":"35","author":"Kato Y.","year":"2015","unstructured":"Kato Y.; Yokoyama U.; Yanai C.; Ishige R.; Kurotaki D.; Umemura M.; Fujita T.; Kubota T.; Okumura S.; Sata M.; Tamura T.; Ishikawa Y.; Epac1 deficiency attenuated vascular smooth muscle cell migration and neointimal formation. Arterioscler Thromb Vasc Biol  2015,35(12),2617-2625","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1161\/ATVBAHA.119.314238","volume":"40","author":"Robichaux W.G.","year":"2020","unstructured":"Robichaux W.G.; Mei F.C.; Yang W.; Wang H.; Sun H.; Zhou Z.; Milewicz D.M.; Teng B.B.; Cheng X.; Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to promote foam cell formation and atherosclerosis development. Arterioscler Thromb Vasc Biol  2020,40(12),e322-e335","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1161\/ATVBAHA.119.314238","volume":"40","author":"Robichaux W.G.","year":"2020","unstructured":"Robichaux W.G.; Mei F.C.; Yang W.; Wang H.; Sun H.; Zhou Z.; Epac1 upregulates LOX-1 to promote foam cell formation and atherosclerosis development. Arterioscler Thromb Vasc Biol  2020,40(12),e322-e335","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jcdd4040022","volume":"4","author":"Barker G.","year":"2017","unstructured":"Barker G.; Parnell E.; van Basten B.; Buist H.; Adams D.; Yarwood S.; The potential of a novel class of EPAC-selective agonists to combat cardiovascular inflammation. J Cardiovasc Dev Dis  2017,4(4),22","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.3390\/ijms23094808","volume":"23","author":"Kotlyarov S.","year":"2022","unstructured":"Kotlyarov S.; Kotlyarova A.; Molecular pharmacology of inflammation resolution in atherosclerosis. Int J Mol Sci  2022,23(9),4808","journal-title":"Int J Mol Sci"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"882","DOI":"10.2174\/138945010791320881","volume":"11","author":"Riccioni G.","year":"2010","unstructured":"Riccioni G.; B\u00e4ck M.; Capra V.; Leukotrienes and atherosclerosis. Curr Drug Targets  2010,11(7),882-887","journal-title":"Curr Drug Targets"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/737282","volume":"2009","author":"Riccioni G.","year":"2009","unstructured":"Riccioni G.; Zanasi A.; Vitulano N.; Mancini B.; D\u2019Orazio N.; Leukotrienes in atherosclerosis: New target insights and future therapy perspectives. Mediators Inflamm  2009,2009,1-6","journal-title":"Mediators Inflamm"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","volume":"16","author":"Basil M.C.","year":"2016","unstructured":"Basil M.C.; Levy B.D.; Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation. Nat Rev Immunol  2016,16(1),51-67","journal-title":"Nat Rev Immunol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fphar.2019.00205","volume":"10","author":"Fredman G.","year":"2019","unstructured":"Fredman G.; Can inflammation-resolution provide clues to treat patients according to their plaque phenotype? Front Pharmacol  2019,10,205","journal-title":"Front Pharmacol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/CIRCRESAHA.121.319822","volume":"130","author":"Doran A.C.","year":"2022","unstructured":"Doran A.C.; Inflammation resolution: Implications for atherosclerosis. Circ Res  2022,130(1),130-148","journal-title":"Circ Res"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/01.ATV.0000110503.16605.15","volume":"24","author":"Subbarao K.","year":"2004","unstructured":"Subbarao K.; Jala V.R.; Mathis S.; Suttles J.; Zacharias W.; Ahamed J.; Ali H.; Tseng M.T.; Haribabu B.; Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler Thromb Vasc Biol  2004,24(2),369-375","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"e86522","DOI":"10.1371\/journal.pone.0086522","volume":"9","author":"van den Borne P.","year":"2014","unstructured":"van den Borne P.; van der Laan S.W.; Bovens S.M.; Koole D.; Kowala M.C.; Michael L.F.; Schoneveld A.H.; van de Weg S.M.; Velema E.; de Vries J.P.; de Borst G.J.; Moll F.L.; de Kleijn D.P.V.; Quax P.H.A.; Hoefer I.E.; Pasterkamp G.; Leukotriene B4 levels in human atherosclerotic plaques and abdominal aortic aneurysms. PLoS One  2014,9(1),e86522","journal-title":"PLoS One"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fimmu.2012.00298","volume":"3","author":"Recchiuti A.","year":"2012","unstructured":"Recchiuti A.; Serhan C.N.; Pro-resolving lipid mediators (SPMs) and their actions in regulating mirna in novel resolution circuits in inflammation. Front Immunol  2012,3,298","journal-title":"Front Immunol"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"Serhan C.N.","year":"2007","unstructured":"Serhan C.N.; Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol  2007,25(1),101-137","journal-title":"Annu Rev Immunol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fphar.2019.01022","volume":"10","author":"Joffre C.","year":"2019","unstructured":"Joffre C.; Rey C.; Lay\u00e9 S.; N-3 polyunsaturated fatty acids and the resolution of neuroinflammation. Front Pharmacol  2019,10,1022","journal-title":"Front Pharmacol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/cells10112963","volume":"10","author":"Sun G.Y.","year":"2021","unstructured":"Sun G.Y.; Geng X.; Teng T.; Yang B.; Appenteng M.K.; Greenlief C.M.; Lee J.C.; Dynamic role of phospholipases a2 in health and diseases in the central nervous system. Cells  2021,10(11),2963","journal-title":"Cells"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","volume":"117","author":"Badimon L.","year":"2021","unstructured":"Badimon L.; Vilahur G.; Rocca B.; Patrono C.; The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovasc Res  2021,117(9),2001-2015","journal-title":"Cardiovasc Res"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1074\/jbc.273.12.6830","volume":"273","author":"Wong J.T.","year":"1998","unstructured":"Wong J.T.; Tran K.; Pierce G.N.; Chan A.C.; O K.; Choy P.C.; Lysophosphatidylcholine stimulates the release of arachidonic acid in human endothelial cells. J Biol Chem  1998,273(12),6830-6836","journal-title":"J Biol Chem"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mvr.2005.01.007","volume":"69","author":"Bogatcheva N.V.","year":"2005","unstructured":"Bogatcheva N.V.; Sergeeva M.G.; Dudek S.M.; Verin A.D.; Arachidonic acid cascade in endothelial pathobiology. Microvasc Res  2005,69(3),107-127","journal-title":"Microvasc Res"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI114503","volume":"85","author":"Serhan C.N.","year":"1990","unstructured":"Serhan C.N.; Sheppard K.A.; Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest  1990,85(3),772-780","journal-title":"J Clin Invest"},{"key":"ref=173","unstructured":"Lipoxins: Novel series of biologically active compounds formed from arachidonic acid in human leukocytes.  Available from:  https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC391698\/"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","volume":"1851","author":"R\u00e5dmark O.","year":"2015","unstructured":"R\u00e5dmark O.; Werz O.; Steinhilber D.; Samuelsson B.; 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta Mol Cell Biol Lipids  2015,1851(4),331-339","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1021\/cr200246d","volume":"111","author":"Haeggstr\u00f6m J.Z.","year":"2011","unstructured":"Haeggstr\u00f6m J.Z.; Funk C.D.; Lipoxygenase and leukotriene pathways: Biochemistry, biology, and roles in disease. Chem Rev  2011,111(10),5866-5898","journal-title":"Chem Rev"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"8161","DOI":"10.1073\/pnas.0602414103","volume":"103","author":"Qiu H.","year":"2006","unstructured":"Qiu H.; Gabrielsen A.; Agardh H.E.; Wan M.; Wetterholm A.; Wong C.H.; Hedin U.; Swedenborg J.; Hansson G.K.; Samuelsson B.; Paulsson-Berne G.; Haeggstr\u00f6m J.Z.; Expression of 5-lipoxygenase and leukotriene A  hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc Natl Acad Sci  2006,103(21),8161-8166","journal-title":"Proc Natl Acad Sci"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10787-022-00942-y","volume":"30","author":"Yuan J.","year":"2022","unstructured":"Yuan J.; Lin F.; Chen L.; Chen W.; Pan X.; Bai Y.; Cai Y.; Lu H.; Lipoxin A4 regulates M1\/M2 macrophage polarization via FPR2\u2013IRF pathway. Inflammopharmacology  2022,30(2),487-498","journal-title":"Inflammopharmacology"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2018.09.025","volume":"278","author":"Mai J.","year":"2018","unstructured":"Mai J.; Liu W.; Fang Y.; Zhang S.; Qiu Q.; Yang Y.; Wang X.; Huang T.; Zhang H.; Xie Y.; Lin M.; Chen Y.; Wang J.; The atheroprotective role of lipoxin A prevents oxLDL-induced apoptotic signaling in macrophages via JNK pathway. Atherosclerosis  2018,278,259-268","journal-title":"Atherosclerosis"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1160\/TH06-06-0315","volume":"97","author":"Nascimento-Silva V.","year":"2007","unstructured":"Nascimento-Silva V.; Arruda M.A.; Barja-Fidalgo C.; Fierro I.M.; Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: A novel antioxidative mechanism. Thromb Haemost  2007,97(1),88-98","journal-title":"Thromb Haemost"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1111\/bph.13707","volume":"174","author":"Petri M.H.","year":"2017","unstructured":"Petri M.H.; Laguna-Fernandez A.; Arnardottir H.; Wheelock C.E.; Perretti M.; Hansson G.K.; B\u00e4ck M.; Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E mice. Br J Pharmacol  2017,174(22),4043-4054","journal-title":"Br J Pharmacol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2337\/db17-1317","volume":"67","author":"Brennan E.P.","year":"2018","unstructured":"Brennan E.P.; Mohan M.; McClelland A.; de Gaetano M.; Tikellis C.; Marai M.; Crean D.; Dai A.; Beuscart O.; Derouiche S.; Gray S.P.; Pickering R.; Tan S.M.; Godson-Treacy M.; Sheehan S.; Dowdall J.F.; Barry M.; Belton O.; Ali-Shah S.T.; Guiry P.J.; Jandeleit-Dahm K.; Cooper M.E.; Godson C.; Kantharidis P.; Lipoxins protect against inflammation in diabetes-associated atherosclerosis. Diabetes  2018,67(12),2657-2667","journal-title":"Diabetes"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"106618","DOI":"10.1016\/j.phrs.2022.106618","volume":"187","author":"Chen R.","year":"2023","unstructured":"Chen R.; Li J.; Zhou J.; Wang Y.; Zhao X.; Li N.; Liu W.; Liu C.; Zhou P.; Chen Y.; Yan S.; Song L.; Yan H.; Zhao H.; Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study. Pharmacol Res  2023,187,106618","journal-title":"Pharmacol Res"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1125858","DOI":"10.3389\/fphar.2023.1125858","volume":"14","author":"Millar B.","year":"2023","unstructured":"Millar B.; de Gaetano M.; Posing the rationale for synthetic lipoxin mimetics as an adjuvant treatment to gold standard atherosclerosis therapies. Front Pharmacol  2023,14,1125858","journal-title":"Front Pharmacol"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"Serhan C.N.","year":"2002","unstructured":"Serhan C.N.; Hong S.; Gronert K.; Colgan S.P.; Devchand P.R.; Mirick G.; Moussignac R.L.; Resolvins. J Exp Med  2002,196(8),1025-1037","journal-title":"J Exp Med"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","volume":"64","author":"Serhan C.N.","year":"2018","unstructured":"Serhan C.N.; Chiang N.; Dalli J.; New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Mol Aspects Med  2018,64,1-17","journal-title":"Mol Aspects Med"},{"key":"ref=186","first-page":"68","author":"Serhan C.N.","year":"2006","unstructured":"Serhan C.N.; Resolvins and protectins: Novel lipid mediators in anti-inflammation and resolution. Food Nutr Res  2006,68-78","journal-title":"Food Nutr Res"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.3390\/ijms21207628","volume":"21","author":"Tu\u0142owiecka N.","year":"2020","unstructured":"Tu\u0142owiecka N.; Kotl\u0119ga D.; Prowans P.; Szczuko M.; The role of resolvins: EPA and DHA derivatives can be useful in the prevention and treatment of ischemic stroke. Int J Mol Sci  2020,21(20),7628","journal-title":"Int J Mol Sci"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"155","DOI":"10.12998\/wjcc.v4.i7.155","volume":"4","author":"Moro K.","year":"2016","unstructured":"Moro K.; Nagahashi M.; Ramanathan R.; Takabe K.; Wakai T.; Resolvins and omega three polyunsaturated fatty acids: Clinical implications in inflammatory diseases and cancer. World J Clin Cases  2016,4(7),155-164","journal-title":"World J Clin Cases"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jphs.2021.05.002","volume":"147","author":"Deyama S.","year":"2021","unstructured":"Deyama S.; Minami M.; Kaneda K.; Resolvins as potential candidates for the treatment of major depressive disorder. J Pharmacol Sci  2021,147(1),33-39","journal-title":"J Pharmacol Sci"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-021-01937-3","volume":"40","author":"Mattoscio D.","year":"2021","unstructured":"Mattoscio D.; Isopi E.; Lamolinara A.; Patruno S.; Medda A.; De Cecco F.; Chiocca S.; Iezzi M.; Romano M.; Recchiuti A.; Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes. J Exp Clin Cancer Res  2021,40(1),129","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1084\/jem.20170681","volume":"215","author":"Sulciner M.L.","year":"2018","unstructured":"Sulciner M.L.; Serhan C.N.; Gilligan M.M.; Mudge D.K.; Chang J.; Gartung A.; Lehner K.A.; Bielenberg D.R.; Schmidt B.; Dalli J.; Greene E.R.; Gus-Brautbar Y.; Piwowarski J.; Mammoto T.; Zurakowski D.; Perretti M.; Sukhatme V.P.; Kaipainen A.; Kieran M.W.; Huang S.; Panigrahy D.; Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med  2018,215(1),115-140","journal-title":"J Exp Med"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1517\/14728220902865622","volume":"13","author":"Hisada T.","year":"2009","unstructured":"Hisada T.; Ishizuka T.; Aoki H.; Mori M.; Resolvin E1 as a novel agent for the treatment of asthma. Expert Opin Ther Targets  2009,13(5),513-522","journal-title":"Expert Opin Ther Targets"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"Serhan C.N.","year":"2008","unstructured":"Serhan C.N.; Chiang N.; Van Dyke T.E.; Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol  2008,8(5),349-361","journal-title":"Nat Rev Immunol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"174527","DOI":"10.1016\/j.ejphar.2021.174527","volume":"911","author":"Molaei E.","year":"2021","unstructured":"Molaei E.; Molaei A.; Hayes A.W.; Karimi G.; Resolvin D1, therapeutic target in acute respiratory distress syndrome. Eur J Pharmacol  2021,911,174527","journal-title":"Eur J Pharmacol"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/ATVBAHA.115.305324","volume":"35","author":"Hasturk H.","year":"2015","unstructured":"Hasturk H.; Abdallah R.; Kantarci A.; Nguyen D.; Giordano N.; Hamilton J.; Van Dyke T.E.; Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler Thromb Vasc Biol  2015,35(5),1123-1133","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"115075","DOI":"10.1016\/j.bcp.2022.115075","volume":"201","author":"Bardin M.","year":"2022","unstructured":"Bardin M.; Pawelzik S.C.; Lagrange J.; Mahdi A.; Arnardottir H.; Regnault V.; F\u00e8ve B.; Lacolley P.; Michel J.B.; Mercier N.; B\u00e4ck M.; The resolvin D2 \u2013 GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice. Biochem Pharmacol  2022,201,115075","journal-title":"Biochem Pharmacol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1038\/ncomms12859","volume":"7","author":"Fredman G.","year":"2016","unstructured":"Fredman G.; Hellmann J.; Proto J.D.; Kuriakose G.; Colas R.A.; Dorweiler B.; Connolly E.S.; Solomon R.; Jones D.M.; Heyer E.J.; Spite M.; Tabas I.; An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat Commun  2016,7(1),12859","journal-title":"Nat Commun"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"923413","DOI":"10.3389\/fcvm.2022.923413","volume":"9","author":"Liu M.","year":"2022","unstructured":"Liu M.; He H.; Chen L.; Protective potential of maresins in cardiovascular diseases. Front Cardiovasc Med  2022,9,923413","journal-title":"Front Cardiovasc Med"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/ijms23031367","volume":"23","author":"Saito-Sasaki N.","year":"2022","unstructured":"Saito-Sasaki N.; Sawada Y.; Nakamura M.; Maresin-1 and inflammatory disease. Int J Mol Sci  2022,23(3),1367","journal-title":"Int J Mol Sci"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/CIRCRESAHA.116.309492","volume":"119","author":"Viola J.R.","year":"2016","unstructured":"Viola J.R.; Lemnitzer P.; Jansen Y.; Csaba G.; Winter C.; Neideck C.; Silvestre-Roig C.; Dittmar G.; D\u00f6ring Y.; Drechsler M.; Weber C.; Zimmer R.; Cenac N.; Soehnlein O.; Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ Res  2016,119(9),1030-1038","journal-title":"Circ Res"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1096\/fj.201700082R","volume":"31","author":"Chatterjee A.","year":"2017","unstructured":"Chatterjee A.; Komshian S.; Sansbury B.E.; Wu B.; Mottola G.; Chen M.; Spite M.; Conte M.S.; Biosynthesis of proresolving lipid mediators by vascular cells and tissues. FASEB J  2017,31(8),3393-3402","journal-title":"FASEB J"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.bcp.2023.115876","volume":"218","author":"Al Zein M.","year":"2023","unstructured":"Al Zein M.; Zein O.; Diab R.; Dimachkie L.; Sahebkar A.; Al-Asmakh M.; Kobeissy F.; Eid A.H.; Intermittent fasting favorably modulates adipokines and potentially attenuates atherosclerosis. Biochem Pharmacol  2023,218,115876","journal-title":"Biochem Pharmacol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"1235953","DOI":"10.3389\/fcvm.2023.1235953","volume":"10","author":"Luo J.","year":"2023","unstructured":"Luo J.; He Z.; Li Q.; Lv M.; Cai Y.; Ke W.; Niu X.; Zhang Z.; Adipokines in atherosclerosis: Unraveling complex roles. Front Cardiovasc Med  2023,10,1235953","journal-title":"Front Cardiovasc Med"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"Liu L.","year":"2022","unstructured":"Liu L.; Shi Z.; Ji X.; Zhang W.; Luan J.; Zahr T.; Qiang L.; Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci  2022,79(5),272","journal-title":"Cell Mol Life Sci"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","volume":"8","author":"Wang Z.V.","year":"2016","unstructured":"Wang Z.V.; Scherer P.E.; Adiponectin, the past two decades. J Mol Cell Biol  2016,8(2),93-100","journal-title":"J Mol Cell Biol"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"Scherer P.E.","year":"1995","unstructured":"Scherer P.E.; Williams S.; Fogliano M.; Baldini G.; Lodish H.F.; A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem  1995,270(45),26746-26749","journal-title":"J Biol Chem"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/ijms20051190","volume":"20","author":"Yanai H.","year":"2019","unstructured":"Yanai H.; Yoshida H.; Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: Msechanisms and perspectives. Int J Mol Sci  2019,20(5),1190","journal-title":"Int J Mol Sci"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"e36076","DOI":"10.1097\/MD.0000000000036076","volume":"102","author":"Wang C.","year":"2023","unstructured":"Wang C.; Chang L.; Wang J.; Xia L.; Cao L.; Wang W.; Xu J.; Gao H.; Leptin and risk factors for atherosclerosis: A review. Medicine  2023,102(46),e36076","journal-title":"Medicine"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.3390\/ijms22115446","volume":"22","author":"Raman P.","year":"2021","unstructured":"Raman P.; Khanal S.; Leptin in atherosclerosis: Focus on macrophages, endothelial and smooth muscle cells. Int J Mol Sci  2021,22(11),5446","journal-title":"Int J Mol Sci"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"E474","DOI":"10.1152\/ajpendo.90369.2008","volume":"297","author":"Hongo S.","year":"2009","unstructured":"Hongo S.; Watanabe T.; Arita S.; Kanome T.; Kageyama H.; Shioda S.; Miyazaki A.; Leptin modulates ACAT1 expression and cholesterol efflux from human macrophages. Am J Physiol Endocrinol Metab  2009,297(2),E474-E482","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.numecd.2022.11.023","volume":"33","author":"Ali S.","year":"2023","unstructured":"Ali S.; Alam R.; Ahsan H.; Khan S.; Role of adipokines (omentin and visfatin) in coronary artery disease. Nutr Metab Cardiovasc Dis  2023,33(3),483-493","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/biomedicines11051290","volume":"11","author":"Clemente-Su\u00e1rez V.J.","year":"2023","unstructured":"Clemente-Su\u00e1rez V.J.; Redondo-Fl\u00f3rez L.; Beltr\u00e1n-Velasco A.I.; Mart\u00edn-Rodr\u00edguez A.; Mart\u00ednez-Guardado I.; Navarro-Jim\u00e9nez E.; Laborde-C\u00e1rdenas C.C.; Tornero-Aguilera J.F.; The role of adipokines in health and disease. Biomedicines  2023,11(5),1290","journal-title":"Biomedicines"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/cells9112444","volume":"9","author":"Dakroub A.","year":"2020","unstructured":"Dakroub A.; A Nasser S.; Younis N.; Bhagani H.; Al-Dhaheri Y.; Pintus G.; Eid A.A.; El-Yazbi A.F.; Eid A.H.; Visfatin: A possible role in cardiovasculo-metabolic disorders. Cells  2020,9(11),2444","journal-title":"Cells"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1002\/jcp.30345","volume":"236","author":"Dakroub A.","year":"2021","unstructured":"Dakroub A.; Nasser S.A.; Kobeissy F.; Yassine H.M.; Orekhov A.; Sharifi-Rad J.; Iratni R.; El-Yazbi A.F.; Eid A.H.; Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases. J Cell Physiol  2021,236(9),6282-6296","journal-title":"J Cell Physiol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673303369240312092913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228125\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673303369240312092913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:44:20Z","timestamp":1748961860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228125\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":214,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673303369240312092913","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}